prevention of these diseases and the demand for new
protective substances prompted us to screen the protective
activity of the mushroom extracts. We previously reported
the protective function of dilinoleoylphosphatidylethanol-
amine that was isolated from the mushroom Hericium
erinaceum.5 Moreover, we have found new ER stress
protective compounds from the mushroom H. erinaceum6,7
and Mycoleptodonoides aitchisonii.8 During the screening
for ER stress protecting effects of the extracts of various
mushrooms, we found relatively strong activity in the extract
of the mushroom Termitomyces titanicus and tried to isolate
the active principles from the mushroom. T. titanicus with a
cap diameter of up to 1 m is the largest edible mushroom in
the world according to Guinness Book of Records. It is
typified by symbiotic life together with termites. Termites
cultivate the mycelia in their nest and fruiting bodies can be
seen arising on or near the mounds.9 Here, we describe the
isolation, structural elucidation, and biological activity of
termitomycamides A to E (1 to 5).
column chromatography, followed by HPLC to afford
compounds 1, 2, and 5 (0.5, 3.4, and 1.0 mg, respectively).
On the other hand, the EtOH soluble fraction was partitioned
between 1-BuOH and H2O. The BuOH soluble part was
fractionated by gel permeation chromatography, silica gel
flash column chromatography, and HPLC to give compounds
3 (3.3 mg) and 4 (1.7 mg).
Termitomycamide A (1) was isolated as a colorless oil.
Its molecular formula was determined as C26H39NO3
by HRESIMS [m/z 436.2824 [M + Na]+ (calcd for
C26H39NaNO3, 436.2828)]. The complete assignment of all
the protons and carbons was accomplished by DEPT,
HMQC, COSY, and HMBC experiments as shown in Table
1. The DEPT experiment indicated the presence of a methyl,
Table 1. NMR Spectroscopic Data for Termitomycamide A (1)a
position δH (mult, J in Hz)
δC
HMBC
1
2
3
174.2
36.6
25.6
2.32 (t, 7.8)
1.67 (m)
C-1
C-2
4-7, 15 1.23-1.37 (m)
29.1, 29.2, 29.2
29.3, 29.6
8, 14
9, 13
10, 12
11
2.03 (m), 2.03 (m) 27.2, 27.2
C-9, 10, 12, 13, 16
C-8, 11, 14
C-8, 11, 14
5.36 (m), 5.36 (m) 130.2, 130.5
5.33 (m), 5.33 (m) 127.9, 128.0
2.75 (dd, 6.8, 6.4) 25.6
C-9, 10, 12, 13
16
17
18
1′
1.28 (m)
1.28 (m)
0.87 (t, 6.9)
4.64 (s)
31.5
22.6
14.1
46.0
C-16, 17
C-1, 2′
2′
1′′
2′′, 6′′
3′′, 5′′
4′′
192.2
126.9
130.5
116.0
161.9
7.77 (d, 8.5)
6.91 (d, 8.5)
C-2′, 1′′, 4′′
C-1′′, 4′′
a CDCl3, 500 MHz.
Powders of the dried fruiting bodies of T. titanicus (3.3
kg) were extracted with hexane, EtOAc, and EtOH, succes-
sively. Since the EtOAc and EtOH soluble fractions showed
the protective activity against ER stress-dependent cell death,
the EtOAc soluble fraction was separated using silica gel
13 methylenes, 8 methines, and 4 quaternary carbons. The
COSY and HMBC correlations are illustrated in Figure 1.
The NMR spectra suggested the presence of a linoleyl moiety
including two disubstituted double bonds [δH 5.36 (H-9, H-13,
2H), δH 5.33 (H-10, H-12, 2H); δC 127.9 (C-9), 128.0 (C-10),
130.2 (C-12), 130.5 (C-13), 174.2 (C-1)]. The 2-amino-1-(4-
hydroxyphenyl)ethanone moiety was confirmed by the COSY
correlations (H-2′′/H-3′′, H-5′′/H-6′′), HMBC correlations (H-
1′/C-2′, H-2′′/C-2′, H-2′′/C-1′′, H-2′′/C-4′′, H-3′′/C-1′′, H-3′′/
C-4′′), and chemical shifts of H-1′ (δH 4.64) and C-2′ (δC 192.2).
The connection between the amine and linoleyl moiety was
indicated by the HMBC correlation from H-1′ to the amide
carbonyl at C-1 (δC 174.2), the lower chemical shift of H-1′
(δH 4.64), and the molecular formula of 1.
Termitomycamide B (2) was purified as a colorless oil. Its
molecular formula was determined as C28H40N2O2 by HRES-
IMS [m/z 459.2990 [M + Na]+ (calcd for C28H40NaN2O2,
459.2988)]. The 1H and 13C NMR data of the position from 1
to 18, C-1′, and C-2′ of 2 were very similar to those of 1. The
indole moiety was constructed by the COSY correlations
(1) Lindholm, D.; Wootz, H.; Korhonen, L. Cell Death Differ. 2006,
13, 385
.
(2) Katayama, T.; Imaizumi, K.; Sato, N.; Miyoshi, K.; Kudo, T.; Hitomi,
J.; Morihara, T.; Yoneda, T.; Gomi, F.; Mori, Y.; Nakano, Y.; Takeda, J.;
Tsuda, T.; Itoyama, Y.; Murayama, O.; Takashima, A.; St George-Hyslop,
P.; Takeda, M.; Tohyama, M. Nat. Cell Biol. 1999, 1, 479
.
(3) Tamatani, M.; Matsuyama, T.; Yamaguchi, A.; Mitsuda, N.;
Tsukamoto, Y.; Taniguchi, M.; Che, Y. H.; Ozawa, K.; Hori, O.; Nishimura,
H.; Yamashita, A.; Okabe, M.; Yanagi, H.; Stern, D. M.; Ogawa, S.;
Tohyama, M. Nat. Med. 2001, 7, 317
(4) Yoshida, H. FEBS J. 2007, 274, 630
(5) Nagai, K.; Chiba, A.; T., N.; Kubota, T.; Kawagishi, H. J. Nutr.
Biochem. 2006, 17, 52
(6) Ueda, K.; Kodani, S.; Kubo, M.; Masuno, K.; Sekiya, A.; Nagai,
.
.
.
K.; Kawagishi, H. Biosci. Biotechnol. Biochem. 2009, 73, 1908
.
(7) Ueda, K.; Tsujimori, M.; Kodani, S.; Chiba, A.; Kubo, M.; Masuno,
K.; Sekiya, A.; Nagai, K.; Kawagishi, H. Bioorg. Med. Chem. 2008, 16,
9467
.
(8) Choi, J.-H.; Horikawa, M.; Okumura, H.; Kodani, S.; Nagai, K.;
Hashizume, D.; Koshino, H.; Kawagishi, H. Tetrahedron 2009, 65, 221.
(9) Piearce, G. D. Mycologist 1987, 1, 111.
(10) Wyffels, L.; Muccioli, G. G.; Bruyne, S. D.; Moerman, L.; Sambre,
J.; Lambert, D. M.; Vos, F. D. J. Med. Chem. 2009, 52, 4613.
Org. Lett., Vol. 12, No. 21, 2010
5013